HeartBeam, Inc.

BEAT

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001779372

SEC filings (opens in a new tab)

No open-market purchases or sales by HeartBeam, Inc. insiders were filed in the last 90 days; 41 institutions reported holding it in 13F filings for Q2 2026, worth $6.08M in total; no superinvestor holds it.

Other share classesBEATW

Key figures

Market capClose on Nov 12, 2026: $25.6M
Insider buysOpen market, last 90 days: 0
Insider sellsOpen market, last 90 days: 0
13F holdersQ2 2026, +3 vs. previous quarter: 41
13F valueReported value at the end of Q2 2026: $6.08M
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: –; No comparable prior period
Net income, FY2025: -$21.0M; No comparable prior period
Free cash flow, FY2025: -$14.6M; No comparable prior period
Revenue, Q3 FY2026: –; No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 2.27M; Shares sold short
Change: −214.7K; −8.6% vs. previous
Days to cover: 1.60; At average daily volume

Superinvestors holding BEAT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding BEAT at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by HeartBeam, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Apr 24, 2026 (view filing)	Apr 16	8 days	Ferrari Richard MDirector	PPurchase	+57.5K	$0.80	+$46.0K	+25.1%286.6K after	Amended
Apr 16, 2026 (view filing)	Apr 16	Same day	Cruickshank TimCFO	PPurchase	+31.3K	$0.80	+$25.0K	+76.3%72.2K after
Apr 16, 2026 (view filing)	Apr 16	Same day	Elfrink WillhemDirector	PPurchase	+187.5K	$0.80	+$150.0K	+53.4%538.7K after
Apr 16, 2026 (view filing)	Apr 16	Same day	Jaff Michael RDirector	PPurchase	+31.3K	$0.80	+$25.0K	New position31.3K after
Apr 16, 2026 (view filing)	Apr 16	Same day	Vajdic BranislavDirector	PPurchase	+31.3K	$0.80	+$25.0K	+3.6%909.9K after
Apr 16, 2026 (view filing)	Apr 16	Same day	ENO Robert PaulPresident	PPurchase	+12.5K	$0.80	+$10.0K	+51.6%36.7K after
Apr 16, 2026 (view filing)	Apr 16	Same day	Ortigas-Wedekind MargaDirector	PPurchase	+25.0K	$0.80	+$20.0K	+22.3%137.3K after
Apr 16, 2026 (view filing)	Apr 16	Same day	Strome Mark EDirector	PPurchase	+750.0K	$0.80	+$600.0K	+25.9%3.65M after
Dec 22, 2025 (view filing)	Dec 17	5 daysLate	Strome Mark E10% Owner	SSale	−250.0K	$3.58	−$895.0K	−7.9%2.90M after
Dec 19, 2025 (view filing)	Dec 17-18	2 days	De Urioste GeorgeDirector	SSale	−57.1K	$3.19	−$182.1K	−100.0%0 after	2 lots

Top 10 13F holders, Q2 2026

See all 41 holders

The largest institutional positions in HeartBeam, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding BEAT in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Vanguard Capital Management LLC	2,137,512	$1.60M	0.00%	+939,719+78.5%	Added
BlackRock, Inc.	987,837	$740.9K	0.00%	+89,516+10.0%	Added
Corsair Capital Management, L.P.	912,500	$684.4K	0.09%	+912,500	New
Bleichroeder LP	625,000	$468.8K	0.08%	+625,000	New
Geode Capital Management, LLC	479,386	$359.6K	0.00%	+102,174+27.1%	Added
Smith, Salley & Associates	367,647	$275.7K	0.01%	00.0%	Unchanged
UBS Group AG	298,917	$224.2K	0.00%	−36,272−10.8%	Reduced
Vanguard Fiduciary Trust Co	274,818	$206.1K	0.00%	+124,756+83.1%	Added
Sigma Planning Corp	247,700	$185.8K	0.00%	+115,150+86.9%	Added
Beacon Pointe Advisors, LLC	247,058	$185.3K	0.00%	−400−0.2%	Reduced

Holders of 5% or more of BEAT

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of HeartBeam, Inc..

Largest holders of BEAT from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Strome Mark E	13D/A	6.80%3.76M shares	–	Oct 25, 20232 filings	Aug 13, 2026	SEC